WO2001043772A3 - Verfahren und vorrichtung zur herstellung eines autologen immunisierungsimpfstoffes gegen krebserkrankungen (tumorvakzine) - Google Patents

Verfahren und vorrichtung zur herstellung eines autologen immunisierungsimpfstoffes gegen krebserkrankungen (tumorvakzine) Download PDF

Info

Publication number
WO2001043772A3
WO2001043772A3 PCT/DE2000/004608 DE0004608W WO0143772A3 WO 2001043772 A3 WO2001043772 A3 WO 2001043772A3 DE 0004608 W DE0004608 W DE 0004608W WO 0143772 A3 WO0143772 A3 WO 0143772A3
Authority
WO
WIPO (PCT)
Prior art keywords
vaccine
producing
cancerous diseases
tumour
against cancerous
Prior art date
Application number
PCT/DE2000/004608
Other languages
English (en)
French (fr)
Other versions
WO2001043772A2 (de
Inventor
Gerhard Mueller
Ewa Krasicka-Rohde
Uwe Bindig
Juergen Beuthan
Cathrin Dressler
Olaf Minet
Carsten Philipp
Hans-Peter Berlien
Original Assignee
Laser & Med Tech Gmbh
Gerhard Mueller
Krasicka Rohde Ewa
Uwe Bindig
Juergen Beuthan
Cathrin Dressler
Olaf Minet
Carsten Philipp
Berlien Hans Peter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laser & Med Tech Gmbh, Gerhard Mueller, Krasicka Rohde Ewa, Uwe Bindig, Juergen Beuthan, Cathrin Dressler, Olaf Minet, Carsten Philipp, Berlien Hans Peter filed Critical Laser & Med Tech Gmbh
Publication of WO2001043772A2 publication Critical patent/WO2001043772A2/de
Publication of WO2001043772A3 publication Critical patent/WO2001043772A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Es soll ein Verfahren und eine Vorrichtung entwickelt werden, mittels derer es gelingt vitale, aus dem Körper des Menschen oder des Tieres gewonnene Tumorzellen derart zu modifizieren, dass sie, inaktiviert, jedoch das Immunsystem des Lebewesens stimulierend, im Rahmen einer einfachen oder Mehrfach-Impfung dem lebeden Organismus wieder zugeführt werden können.
PCT/DE2000/004608 1999-12-16 2000-12-18 Verfahren und vorrichtung zur herstellung eines autologen immunisierungsimpfstoffes gegen krebserkrankungen (tumorvakzine) WO2001043772A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19960705.2 1999-12-16
DE19960705A DE19960705A1 (de) 1999-12-16 1999-12-16 Verfahren und Vorrichtung zur Herstellung eines autologen Immunisierungsimpfstoffes gegen Krebserkrankungen (Tumorvakzine)

Publications (2)

Publication Number Publication Date
WO2001043772A2 WO2001043772A2 (de) 2001-06-21
WO2001043772A3 true WO2001043772A3 (de) 2002-03-07

Family

ID=7932892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2000/004608 WO2001043772A2 (de) 1999-12-16 2000-12-18 Verfahren und vorrichtung zur herstellung eines autologen immunisierungsimpfstoffes gegen krebserkrankungen (tumorvakzine)

Country Status (2)

Country Link
DE (1) DE19960705A1 (de)
WO (1) WO2001043772A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4394334B2 (ja) * 2002-06-25 2010-01-06 浜松ホトニクス株式会社 脈管病に関する光物理化学的診断・治療薬
JP2006306743A (ja) * 2005-04-26 2006-11-09 Hamamatsu Photonics Kk 体液処理方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571082A (en) * 1993-08-02 1996-11-05 Bashikirov; Alexei B. Method of producing therapeutic effect upon an organism to reduce the pathologic lymphocyte population
WO1997034472A1 (en) * 1996-03-22 1997-09-25 Yale University Methods for inducing immune responsiveness in a subject
US5736563A (en) * 1992-09-21 1998-04-07 Quadra Logic Technologies, Inc. Transcutaneous in vivo activation of photosensitive agents in blood
WO1999038380A1 (en) * 1998-01-28 1999-08-05 Yale University Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736563A (en) * 1992-09-21 1998-04-07 Quadra Logic Technologies, Inc. Transcutaneous in vivo activation of photosensitive agents in blood
US5571082A (en) * 1993-08-02 1996-11-05 Bashikirov; Alexei B. Method of producing therapeutic effect upon an organism to reduce the pathologic lymphocyte population
WO1997034472A1 (en) * 1996-03-22 1997-09-25 Yale University Methods for inducing immune responsiveness in a subject
WO1999038380A1 (en) * 1998-01-28 1999-08-05 Yale University Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BEUTHAN J ET AL: "OBSERVATIONS OF THE FLUORESCENCE RESPONSE OF THE COENZYME NADH IN BIOLOGICAL SAMPLES", OPTICS LETTERS,US,OPTICAL SOCIETY OF AMERICA, WASHINGTON, vol. 18, no. 13, 1 July 1993 (1993-07-01), pages 1098 - 1100, XP000372748, ISSN: 0146-9592 *

Also Published As

Publication number Publication date
WO2001043772A2 (de) 2001-06-21
DE19960705A1 (de) 2001-06-21

Similar Documents

Publication Publication Date Title
BR0316758A (pt) Vacinas baseadas em levedura como imunoterapia
IL96893A0 (en) Vaccines against cancer and infectious diseases
IL211038A0 (en) A method for identification, isolation and production of antigens to a specific pathogen
DE69723434D1 (de) Verfahren zur selektion und produktion von t-zell-peptide epitope und vakzine mit diese epitope
WO2007092939A3 (en) Antigenic gm-csf peptides and antibodies to gm-csf
WO2005099369A3 (en) Emr treated islets
WO2008057235A3 (en) Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
EP0077734A3 (de) Herstellung von monoklonalen Antikörpern gegen bakterielle Adhesine
IL138798A0 (en) Vaccines and antibodies against bacterial pneumococcal infection
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
EP1385541A4 (de) Immunostimulierende zusammnensetzungen die aminoalkyl glucosaminidephosphat und qs-21 enthalten
WO2022155541A8 (en) Interferon prodrugs and methods of making and using the same
WO2003090687A8 (en) Using heat shock proteins to increase immune response
WO2004044155A3 (en) MIP-1α AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE
DK1146906T3 (da) Mukosalt afgivelsessystem
WO2001043772A3 (de) Verfahren und vorrichtung zur herstellung eines autologen immunisierungsimpfstoffes gegen krebserkrankungen (tumorvakzine)
WO1997047271A3 (en) Cellular vaccines and immunotherapeutics and methods for their preparation
WO2004027036A3 (en) Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
IL148741A0 (en) Vaccine
WO2003093298A3 (en) Immunogenic peptides
WO2004084935A3 (en) Francisella strain for live vaccine
IL122829A (en) Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
AU2579600A (en) Product and method for obtaining specific immunisation with one or more antigens
WO2003074003A3 (en) Immunogens for treatment of neoplastic and infectious disease
RU2000102946A (ru) Способ вакцинотерапии онкозаболеваний

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP